QM
MRVI icon

QVIDTVM Management’s Maravai LifeSciences MRVI Stock Holding History

QVIDTVM Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-163,230
Closed -$1.07M – 11
2023
Q4 		$1.07M Hold
163,230
– – 0.9% 7
2023
Q3 		$1.63M Buy
+163,230
New +$1.79M 1.27% 10

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QVIDTVM Management's MRVI Position: Q1 2024 in Review

QVIDTVM Management sold out of Maravai LifeSciences (MRVI) in Q1 2024, closing a stake of 163,230 shares — an estimated $1.07M sold.

QVIDTVM Management first reported a position in MRVI in Q3 2023 and held it in 2 quarters. The position peaked at $1.63M in Q3 2023. 210 funds tracked by Wall St. Rank hold MRVI as of Q1 2024.

  • QVIDTVM Management reported no remaining Maravai LifeSciences position as of Q1 2024 after selling out during the quarter.
  • QVIDTVM Management sold 163,230 Maravai LifeSciences shares in Q1 2024, an estimated $1.07M.
  • QVIDTVM Management first reported a position in Maravai LifeSciences in Q3 2023 and held it in 2 quarters.
  • QVIDTVM Management's Maravai LifeSciences position peaked at $1.63M in Q3 2023.
  • 210 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2024.

Based on QVIDTVM Management's 13F filing for Q1 2024, filed 14 May 2024.